Carlos Company

9 papers and 495 indexed citations i.

About

Carlos Company is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Carlos Company has authored 9 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Immunology and 2 papers in Cancer Research. Recurrent topics in Carlos Company’s work include Immune Response and Inflammation (2 papers), Immune Cell Function and Interaction (2 papers) and Immune cells in cancer (2 papers). Carlos Company is often cited by papers focused on Immune Response and Inflammation (2 papers), Immune Cell Function and Interaction (2 papers) and Immune cells in cancer (2 papers). Carlos Company collaborates with scholars based in Spain, United States and Italy. Carlos Company's co-authors include Esteban Ballestar, Javier Rodríguez‐Ubreva, Damiana Álvarez‐Errico, Roser Vento‐Tormo, José Urquiza, Lorenzo de la Rica, Laura Ciudad, Francesc Català‐Moll, Ricardo N. Ramírez and Nataša Obermajer and has published in prestigious journals such as Nature Communications, The Journal of Immunology and Scientific Reports.

In The Last Decade

Co-authorship network of co-authors of Carlos Company i

Fields of papers citing papers by Carlos Company

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos Company. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Company. The network helps show where Carlos Company may publish in the future.

Countries citing papers authored by Carlos Company

Since Specialization
Citations

This map shows the geographic impact of Carlos Company's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Company with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Company more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2025